Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.
ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.
ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.
The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.
Sustained Acoustic Medicine developer avoids supply chain tangles to supply healthcare providers with needed medical intervention.
New research demonstrates how sustained acoustic medicine (SAM) accelerates healing and recovery from soft tissue injury common in college and professional sports
Cutting-edge sustained acoustic medicine soft tissue healing treatment developed in partnership with federal research support will now help federal workers recover from injury and improve surgery outcomes.
Wearable ultrasound sam® device heals soft tissue injuries faster, reduces need for surgery and pain medications.
Groundbreaking ultrasound therapy company helps the Whale and other sports teams recover, manage pain and stay in the game
Wearable ultrasound therapy for home use assists in healing and reduces reliance on narcotic pain medications, which only mask pain
ZetrOZ's Sustained Acoustic Medicine (samⓇ) backed by 15 years of research, 30 clinical studies, 300,000 patients
The wearable sustained acoustic medicine (sam®) device has been leveraged by athletes to help treat injuries sustained during competition
SAMⓇ, the only FDA-cleared, wearable home ultrasound device will display its healing functions at the world's largest event for chiropractic medicine.
ZetrOZ Systems' long-duration ultrasound device provides new options for orthopedic surgeons
American-made products mean more transparency and higher standards, resulting in a better overall product and customer experience.
Company achieves first and only FDA-approved, wearable device for multi-hour continuous ultrasound therapy for home-use.
Dr. George Lewis of ZetrOZ Systems to present results of large clinical trial at Special Operations Medical Association's annual Scientific Assembly
ZetrOZ Systems partners with Dr. Rod Walters, nationally recognized sports medicine clinical educator, for an upcoming course on soft-tissue regeneration and rapid response care.
Retired Army Ranger tells how ZetrOZ Systems' Sustained Acoustic Medicine (SAM) device has helped him rehab from injuries
Structures in the healthcare system often stifle innovation and breakthrough treatments.
Dr. George Lewis outlines benefits and effectiveness of novel technology for non-invasive, non-opioid pain relief
The bill aims to expand provider access to FDA-approved, non-opioid pain management approaches. Sustained Acoustic Medicine, developed by ZetrOZ Systems, is among those approaches.
ZetrOZ and the NIA aim to develop new pain-relieving innovations and help make them available to the public faster.
Review finds ZetrOZ technology also lowers treatment costs significantly improving care for the aging patient population
Spring training means Baseball season is almost underway after an early ending last season due to the pandemic.
sam® wearable ultrasound device has helped career law enforcement officers injured in the line of duty reduce chronic pain and get their lives back.
ZetrOZ is expanding the utilization of Sustained Acoustic Medicine to help 100 million people with soft-tissue injuries and chronic pain
Sustained Acoustic Medicine (SAM) is now part of the majority of university curriculum for Athletic Training, Physical Therapy, and Occupational Therapy students, as well as pre-med students learning about mechanobiology.
Those on government insurance — veterans, state and federal employees — have access to coverage for SAM technology.
ZetrOZ is expanding on the certified SAM CME Education Program, offering multiple CME courses across several delivery platforms with Dr. Rod Walters and Dr. Rajiv Mallipudi.
SAM technology is growing more popular among professional athletes and everyday people for its ability to reduce pain and help recover without invasive surgery. Drug-free and safe.
Sustained acoustic medicine (SAM) technology, approved by the FDA in 2013 for clinical utilization, sees re-approval for expanded indications in 2020.
A 2020 real-world outcomes research study finds athletes utilizing sustained acoustic medicine (SAM) experience average pain decrease, improvement in function and quality of life, and faster return to sport.
ZetrOZ is partnering with the National Women's Hockey League, becoming the official sustained acoustic medical device of the Connecticut Whale
ZetrOZ earns a place on the 2020 Inaugural List of Most Innovative Companies in Healthcare, a list compiled by former Secretary of Veterans Health Administration, Dr. David Shulkin, M.D.
Wearable SAM ultrasound treatment is shown to be a cost-effective solution for the treatment of knee arthritis pain, compared to physical therapy and hyaluronic acid injections.
Sustained Acoustic Medicine (SAM) is helping athletes across sports of all levels — college, minors, pros, and even Olympians — recover from muscular injuries without surgery and be back on the field within weeks. Watch the story: https://www.youtube.com/watch?v=rGXZw1Bke0E&t
sam® technology is the number one prescribed ultrasound device in the professional sports industry.
ZetrOZ's wearable, long-duration, ultrasound technology is clinically proven to treat chronic pain and accelerate natural healing.
The sustained acoustic medicine treatment reduces the cause of pain, accelerates the healing process, delivers mechanical compression, increases deep circulation, enhances oxygen and nutrient delivery and provides daily therapy multiple hours per day. The technology is proven in over 20 clinical trials supporting the efficacy of treatment.
The 2020 FDA-approved, non-invasive, home-use, SAM treatment facilitates the healing of a wide range of injuries and significantly reduces pain - without drugs or surgery. A gamechanger for chronic pain patients and the Veteran Health Administration strategic initiative to reduce opioid abuse.
Those suffering from injuries experience pain relief and healing without the need for expensive surgery, injections or prescription drugs.
By stimulating blood flow for multiple hours a day to a localized region, the wearable device sends a powerful flow of nutrients to the site of an injury